JPM vs Greenhill vs Ducera
Interested in these 3 for their NY offices and want to go to the buy-side after my analyst stint; obviously JPM has top 3 BB prestige (not GS/MS tho) but has group placement risk and a lower return offer rate, Greenhill isn't what it once was but still has solid MM/UMM/MF PE exits, and Ducera pays its analysts $200k+ but has the worst hours and exits generally limited to credit roles. Thoughts?
Choose JPM, if you don't like it or don't get the return offer you would have J.P. Morgan on your CV. Killer.
.
Choose greenhill
Why?
not OP, but at least in the CHI office all greenhill analysts exit to MF/UMM, exits are still top
I think you idea that of Ducera exits being limited is partially due to selection bais. In order to have a shot with them you really need to be passionate about RX and I think that just leads to more moving to credit buyside. I know they had a couple people that exited to HIG and 1 to EQT in the last couple years, which isn't bad given class size. Anyways, if you just want to do M&A, I would say JPM > Greenhill >= Ducera(mix M&A and RX) not sure how much longer Greenhill over Ducera will last, since one is struggle and one is growing.
Ducera over Greenhill
Bump
bump
bump
Personally, I'd choose JP Morgan myself. The JP Morgan brand name is unmatched. Ducera and Greenhill are solid banks nonetheless.
JPM HR burner alert
Care to elaborate?
Gonna go contrarian and say Greenhill. Solid culture, stable buyside placements (better than JPM on an average outcome basis), higher pay than JPM. Would eliminate Ducera as it is too limiting.
Are these things still true? You can't even find Greenhill on league tables anymore while they used to be top 15 ten years ago.
Yes to pay and placements. League tables is not totally indicative of buyside interest. There is a lot of prestige/legacy/preference factor. There was another thread awhile ago that compiled buyside placement from BB's. Credit Suisse was the strongest out of mid-tier BB's even though their deal volume has fallen behind over the past few years.
What’s your thoughts on them at the associate and VP levels?
If you let WSO convince you to take Greenhill over JPM, you shouldn't have a JPM offer. Can't think of a single buy-side firm that hires from Greenhill and not JPM or in preference to them, whereas in any exit outside finance, JPM >>>>> Greenhill.
Agreed but it’s not just about that. It’s more about the people and whom did they connect with in chats interviews etc.., especially if exits are not so important. Given most people exit I do agree…. But id pick ducera personally since I’m really interested in rx… just about preferences yknow
Second GHL. While they've plummeted in league tables and have pretty dog M&A dealflow, they still place really well into buyside due to legacy prestige / recruiting inertia.
nah lol
How much of that buyside placement is rx vs m&a tho?
Doesn't JP have the same prestige factor as well? If M&A deal flow is dead doesn't that mean you're just pitching all the time and MDs are stressed struggling to bring in fees so they take it out on analysts?
JPM definitely has the same prestige factor and a much, much stronger brand globally, but for the purpose of OP's question we cannot ignore group placement risk. If M&A deal flow does indeed "die", how will the MD's react? And how will that affect the analyst experience? It's a hypothetical question that nobody really knows. It is a good thought to ponder on though.
Bump
JPM duh
Did anyone hear back from GHL super day yet?
Bro… jpm over both of those and its not even a question.
Hope this is a troll post. Take JPM and get off WSO.
JMP as long as you can get into a core group (M&A, HC, etc).
...
All are sweaty so just take Jp for prestige and brand recognition if you care about that, or one of the others for the comp
Interested for 2024 recruiting
For prestige exit opps take JPM, the worst that can happen is you end up at ECM or DCM every coverage group at JPM is pretty strong, especially their healthcare team, have seen MF/UMM exits across all groups
If you’re interested in buyout roles or M&A type stuff then JPM hands down. If you know you’re interested in distressed or special situations then Ducera would be best.
Interested to hear what people’s thoughts are given 2022 An1 bonus numbers are widely available now. GHL bonuses averaged $85k and JPM averaged $40-45k. Haven’t seen many Ducera numbers.
Ducera on par with CVP and Qatalyst.
Full time?
This year top bucket was around 80k, mid was around 40k and bottom was 20 10k
Do bottom buckets usually get fired?
Would people say the average PE exit is better at JPM or Greenhill?
JPM (especially in Europe)
Hard to say what an average exit is when JPM analyst classes are so large
GHL still has historically placed a good proportion of their classes into buyside. However, a lot of one's buyside recruiting success comes from the individual and their experiences rather than the bank brand - that only gets the foot in the door.
Bump
Quod exercitationem temporibus doloribus cupiditate quaerat in suscipit. Explicabo rerum magni delectus et voluptas ut dolorem.
Sunt quos nam mollitia et. Illo sit eum impedit. Molestiae a temporibus velit possimus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Ducimus animi pariatur labore ratione quo dolores. Assumenda eaque saepe labore voluptatibus ullam esse provident. Reprehenderit molestiae occaecati omnis illum esse repellat nesciunt velit. Ipsam numquam et fuga et doloribus optio voluptas. Assumenda reprehenderit vero est laudantium maxime est cupiditate occaecati. Et modi quia veniam ex assumenda non. Et accusamus dolorum tempora tenetur harum.
Aut quia at nihil nobis. Ut assumenda voluptatem harum quia voluptas est nobis. Maiores porro quia dolores in. Est nihil voluptas quia consectetur voluptatum quam ut ut.
Veritatis quibusdam non ex id occaecati et animi omnis. Aliquid ut dolorem sint occaecati quisquam vel doloremque. Molestias quaerat amet cupiditate ut. Consectetur ut et maiores fugit quam quod consequuntur doloribus.
Molestias et dolore rem quaerat aut. Labore blanditiis voluptatum modi reprehenderit et vitae deleniti. Rerum maxime eos aut aut id. Praesentium odio dignissimos cum corporis.